The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Advances and challenges in malaria vaccine development
Open accessAbstract
Malaria caused by Plasmodium falciparum remains a major public health threat, especially among children and pregnant women in Africa. An effective malaria vaccine would be a valuable tool to reduce the disease burden and could contribute to elimination of malaria in some regions of the world. Current malaria vaccine candidates are directed against human and mosquito stages of the parasite life cycle, but thus far, relatively few proteins have been studied for potential vaccine development. The most advanced vaccine candidate, RTS,S, conferred partial protection against malaria in phase II clinical trials and is currently being evaluated in a phase III trial in Africa. New vaccine targets need to be identified to improve the chances of developing a highly effective malaria vaccine. A better understanding of the mechanisms of naturally acquired immunity to malaria may lead to insights for vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome sequence of the human malaria parasite Plasmodium falciparum
Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S., et al. (2002) · Nature · doi:10.1038/nature01097 · Cited by 4,407
The global distribution of clinical episodes of Plasmodium falciparum malaria
Snow, R. W., Guerra, C. A., Noor, A. M., Myint, H. Y., & Hay, S. I. (2005) · Nature · doi:10.1038/nature03342 · Cited by 2,741
Gamma-Globulin and Acquired Immunity to Human Malaria
COHEN, S., McGREGOR, I. A., & CARRINGTON, S. (1961) · Nature · doi:10.1038/192733a0 · Cited by 1,393
A proteomic view of the Plasmodium falciparum life cycle
Florens, L., Washburn, M. P., Raine, J. D., Anthony, R. M., Grainger, M., Haynes, J. D., Moch, J. K., Muster, N., Sacci, J. B., Tabb, D. L., et al. (2002) · Nature · doi:10.1038/nature01107 · Cited by 1,308
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108
Invasion of Red Blood Cells by Malaria Parasites
Cowman, A. F., & Crabb, B. S. (2006) · Cell · doi:10.1016/j.cell.2006.02.006 · Cited by 943
Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei
NUSSENZWEIG, R. S., VANDERBERG, J., MOST, H., & ORTON, C. (1967) · Nature · doi:10.1038/216160a0 · Cited by 937
Immunity to malaria: more questions than answers
Langhorne, J., Ndungu, F. M., Sponaas, A.-M., & Marsh, K. (2008) · Nature Immunology · doi:10.1038/ni.f.205 · Cited by 878
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 838
Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Milman, J., Mandomando, I., Spiessens, B., Guinovart, C., Espasa, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17223-1 · Cited by 752
Differentiating the pathologies of cerebral malaria by postmortem parasite counts
Taylor, T. E., Fu, W. J., Carr, R. A., Whitten, R. O., Mueller, J. G., Fosiko, N. G., Lewallen, S., Liomba, N. G., & Molyneux, M. E. (2004) · Nature Medicine · doi:10.1038/nm986 · Cited by 719
Dame, J. B., Williams, J. L., McCutchan, T. F., Weber, J. L., Wirtz, R. A., Hockmeyer, W. T., Maloy, W. L., Haynes, J. D., Schneider, I., Roberts, D., et al. (1984) · Science · doi:10.1126/science.6204383 · Cited by 712
Self-citationSalanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702
Hoffman, S. L., Goh, L. M. L., Luke, T. C., Schneider, I., Le, T. P., Doolan, D. L., Sacci, J., de la Vega, P., Dowler, M., Paul, C., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/339409 · Cited by 688
Bull, P. C., Lowe, B. S., Kortok, M., Molyneux, C. S., Newbold, C. I., & Marsh, K. (1998) · Nature Medicine · doi:10.1038/nm0398-358 · Cited by 645
Artemisinin resistance: current status and scenarios for containment
Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P. J., Socheat, D., & von Seidlein, L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2331 · Cited by 645
Protection against a Malaria Challenge by Sporozoite Inoculation
Roestenberg, M., McCall, M., Hopman, J., Wiersma, J., Luty, A. J. F., van Gemert, G. J., van de Vegte-Bolmer, M., van Schaijk, B., Teelen, K., Arens, T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805832 · Cited by 577
N’Guessan, R., Corbel, V., Akogbéto, M., & Rowland, M. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1302.060631 · Cited by 548
Bouharoun-Tayoun, H., Attanath, P., Sabchareon, A., Chongsuphajaisiddhi, T., & Druilhe, P. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1633 · Cited by 544
Bojang, K. A., Milligan, P. J., Pinder, M., Vigneron, L., Alloueche, A., Kester, K. E., Ballou, W. R., Conway, D. J., Reece, W. H., Gothard, P., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06957-4 · Cited by 528
Kester, K. E., Cummings, J. F., Ofori‐Anyinam, O., Ockenhouse, C. F., Krzych, U., Moris, P., Schwenk, R., Nielsen, R. A., Debebe, Z., Pinelis, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600120 · Cited by 524
Genton, B., Betuela, I., Felger, I., Al‐Yaman, F., Anders, R. F., Saul, A., Rare, L., Baisor, M., Lorry, K., Brown, G. V., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/339342 · Cited by 523
Changes in the burden of malaria in sub-Saharan Africa
O'Meara, W. P., Mangeni, J. N., Steketee, R., & Greenwood, B. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70096-7 · Cited by 522
Antigenic variation in Plasmodium falciparum.
Biggs, B. A., Goozé, L., Wycherley, K., Wollish, W., Southwell, B., Leech, J. H., & Brown, G. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9171 · Cited by 505
Parasitologic and Clinical Human Response to Immunoglobulin Administration in Falciparum Malaria
Sabchareon, A., Burnouf, T., Ouattara, D., Attanath, P., Bouharoun-Tayoun, H., Chantavanich, P., Foucault, C., Chongsuphajaisiddhi, T., & Druilhe, P. (1991) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.45.297 · Cited by 499
Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria
Schofield, L., Hewitt, M. C., Evans, K., Siomos, M.-A., & Seeberger, P. H. (2002) · Nature · doi:10.1038/nature00937 · Cited by 486
Immunity to non-cerebral severe malaria is acquired after one or two infections
Gupta, S., Snow, R. W., Donnelly, C. A., Marsh, K., & Newbold, C. (1999) · Nature Medicine · doi:10.1038/6560 · Cited by 478
Wu, Y., Ellis, R. D., Shaffer, D., Fontes, E., Malkin, E. M., Mahanty, S., Fay, M. P., Narum, D., Rausch, K., Miles, A. P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002636 · Cited by 449
Self-citationAntigenic Variation in Plasmodium falciparum
Scherf, A., Lopez-Rubio, J. J., & Riviere, L. (2008) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.080706.093134 · Cited by 447
Leech, J. H., Barnwell, J. W., Miller, L. H., & Howard, R. J. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.6.1567 · Cited by 437
Self-citationCrompton, P. D., Kayala, M. A., Traore, B., Kayentao, K., Ongoiba, A., Weiss, G. E., Molina, D. M., Burk, C. R., Waisberg, M., Jasinskas, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001323107 · Cited by 420
Self-citationImmune effector mechanisms in malaria
MARSH, K., & KINYANJUI, S. (2006) · Parasite Immunology · doi:10.1111/j.1365-3024.2006.00808.x · Cited by 419
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, T., Gould, J., Dubois, M.-C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807381 · Cited by 417
Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Aide, P., Sigauque, B., Milman, J., Mandomando, I., Bassat, Q., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67669-6 · Cited by 412
Pombo, D. J., Lawrence, G., Hirunpetcharat, C., Rzepczyk, C., Bryden, M., Cloonan, N., Anderson, K., Mahakunkijcharoen, Y., Martin, L. B., Wilson, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09784-2 · Cited by 403
Baruch, D. I., Gormely, J. A., Ma, C., Howard, R. J., & Pasloske, B. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3497 · Cited by 399
A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules
Sinigaglia, F., Guttinger, M., Kilgus, J., Doran, D. M., Matile, H., Etlinger, H., Trzeciak, A., Gillessen, D., & Pink, J. R. L. (1988) · Nature · doi:10.1038/336778a0 · Cited by 384
Ogutu, B. R., Apollo, O. J., McKinney, D., Okoth, W., Siangla, J., Dubovsky, F., Tucker, K., Waitumbi, J. N., Diggs, C., Wittes, J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004708 · Cited by 343
Gordon, D. M., McGovern, T. W., Krzych, U., Cohen, J. C., Schneider, I., LaChance, R., Heppner, D. G., Yuan, G., Hollingdale, M., Slaoui, M., et al. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1576 · Cited by 327
Jensen, A. T. R., Magistrado, P., Sharp, S., Joergensen, L., Lavstsen, T., Chiucchiuini, A., Salanti, A., Vestergaard, L. S., Lusingu, J. P., Hermsen, R., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040274 · Cited by 322
Liu, Y., Tewari, R., Ning, J., Blagborough, A. M., Garbom, S., Pei, J., Grishin, N. V., Steele, R. E., Sinden, R. E., Snell, W. J., et al. (2008) · Genes & Development · doi:10.1101/gad.1656508 · Cited by 320
Hoffman, S. L., Billingsley, P. F., James, E., Richman, A., Loyevsky, M., Li, T., Chakravarty, S., Gunasekera, A., Chattopadhyay, R., Li, M., et al. (2010) · Human Vaccines · doi:10.4161/hv.6.1.10396 · Cited by 297
Adult and child malaria mortality in India: a nationally representative mortality survey
Dhingra, N., Jha, P., Sharma, V. P., Cohen, A. A., Jotkar, R. M., Rodriguez, P. S., Bassani, D. G., Suraweera, W., Laxminarayan, R., & Peto, R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60831-8 · Cited by 284
Aponte, J. J., Aide, P., Renom, M., Mandomando, I., Bassat, Q., Sacarlal, J., Manaca, M. N., Lafuente, S., Barbosa, A., Leach, A., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61542-6 · Cited by 279
Kester, K. E., McKinney, D. A., Tornieporth, N., Ockenhouse, C. F., Heppner, D. G., Hall, T., Krzych, U., Delchambre, M., Voss, G., Dowler, M. G., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318534 · Cited by 271
Profiling humoral immune responses to P. falciparum infection with protein microarrays
Doolan, D. L., Mu, Y., Unal, B., Sundaresh, S., Hirst, S., Valdez, C., Randall, A., Molina, D., Liang, X., Freilich, D. A., et al. (2008) · PROTEOMICS · doi:10.1002/pmic.200800194 · Cited by 257
Parasite ligand–host receptor interactions during invasion of erythrocytes by Plasmodium merozoites
Gaur, D., Mayer, D. C. G., & Miller, L. H. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2004.10.010 · Cited by 243
Self-citationWebster, D. P., Dunachie, S., Vuola, J. M., Berthoud, T., Keating, S., Laidlaw, S. M., McConkey, S. J., Poulton, I., Andrews, L., Andersen, R. F., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406381102 · Cited by 242
Weiss, G. E., Traore, B., Kayentao, K., Ongoiba, A., Doumbo, S., Doumtabe, D., Kone, Y., Dia, S., Guindo, A., Traore, A., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000912 · Cited by 239
Self-citationSafety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
Abdulla, S., Oberholzer, R., Juma, O., Kubhoja, S., Machera, F., Membi, C., Omari, S., Urassa, A., Mshinda, H., Jumanne, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807773 · Cited by 239
Sun, P., Schwenk, R., White, K., Stoute, J. A., Cohen, J., Ballou, W. R., Voss, G., Kester, K. E., Heppner, D. G., & Krzych, U. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6961 · Cited by 232
Hommel, M., David, P. H., & Oligino, L. D. (1983) · The Journal of experimental medicine · doi:10.1084/jem.157.4.1137 · Cited by 227
Kraemer, S. M., & Smith, J. D. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03814.x · Cited by 227
Tsuboi, T., Takeo, S., Iriko, H., Jin, L., Tsuchimochi, M., Matsuda, S., Han, E.-T., Otsuki, H., Kaneko, O., Sattabongkot, J., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01539-07 · Cited by 214
Groux, H., & Gysin, J. (1990) · Research in Immunology · doi:10.1016/0923-2494(90)90021-p · Cited by 203
Quakyi, I. A., Carter, R., Rener, J., Kumar, N., Good, M. F., & Miller, L. H. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4213 · Cited by 195
Self-citationCasares, S., Brumeanu, T.-D., & Richie, T. L. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.033 · Cited by 194
Prime-boost vectored malaria vaccines: Progress and prospects
Hill, A. V. S., Reyes-Sandoval, A., O’Hara, G., Ewer, K., Lawrie, A., Goodman, A., Nicosia, A., Folgori, A., Colloca, S., Cortese, R., et al. (2010) · Human Vaccines · doi:10.4161/hv.6.1.10116 · Cited by 193
Baird, J. K., Jones, T. R., Danudirgo, E. W., Annis, B. A., Bangs, M. J., Hasan Basri, P., & Masbar, S. (1991) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.45.65 · Cited by 188
Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate
Plassmeyer, M. L., Reiter, K., Shimp, R. L., Kotova, S., Smith, P. D., Hurt, D. E., House, B., Zou, X., Zhang, Y., Hickman, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013706 · Cited by 180
Self-citationEvaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
Polhemus, M. E., Remich, S. A., Ogutu, B. R., Waitumbi, J. N., Otieno, L., Apollo, S., Cummings, J. F., Kester, K. E., Ockenhouse, C. F., Stewart, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006465 · Cited by 157
Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera
Graves, P. M., CARTERS, R., Burkot, T. R., et al. (1988) · Parasite Immunology · doi:10.1111/j.1365-3024.1988.tb00215.x · Cited by 157
Lalvani, A., Moris, P., Voss, G., Pathan, A. A., Kester, K. E., Brookes, R. H., Lee, E., Koutsoukos, M., Plebanski, M., Delchambre, M., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315074 · Cited by 155
Long‐Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children
Sacarlal, J., Aíde, P., Aponte, J. J., Renom, M., Leach, A. J., Mandomando, I., Lievens, M., Bassat, Q., Lafuente, S., Macete, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600119 · Cited by 154
Audran, R., Cachat, M., Lurati, F., Soé, S., Leroy, O. Y., Corradin, G., Druilhe, P., & Spertini, F. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.8017-8026.2005 · Cited by 153
Sidelights on malaria in man obtained by subinoculation experiments
Fairley, B. N. H. (1947) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(47)90025-4 · Cited by 151
Malaria transmission-blocking vaccines—how can their development be supported?
Carter, R., Mendis, K., Miller, L. H., Molineaux, L., & Saul, A. J. (2000) · Nature Medicine · doi:10.1038/73062 · Cited by 151
Self-citationKester, K. E., Cummings, J. F., Ockenhouse, C. F., Nielsen, R. K., Hall, B. T., Gordon, D. M., Schwenk, R., Krzych, U., Holland, C. A., Richmond, G., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.02.048 · Cited by 144
Lawrence, G., Cheng, Q., Reed, C., Taylor, D. F., Stowers, A. W., Cloonan, N., Rzepczyk, C. M., Smillie, A., Anderson, K., Pombo, D., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00444-2 · Cited by 139
Bejon, P., Mwacharo, J. K., Kai, O. K., Mwangi, T., Milligan, P. J., Todryk, S. M., Keating, S. M., Lang, T. A., Lowe, B. S., Gikonyo, C., et al. (2006) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0010029 · Cited by 137
Simpson, J. A., Aarons, L. J., Collins, W. E., Jeffery, G. M., & White, N. J. (2002) · Parasitology · doi:10.1017/s0031182001001202 · Cited by 136
Detecting signatures of balancing selection to identify targets of anti-parasite immunity
Weedall, G. D., & Conway, D. J. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2010.04.002 · Cited by 135
Genetically engineered, attenuated whole-cell vaccine approaches for malaria
Vaughan, A. M., Wang, R., & Kappe, S. H. I. (2010) · Human Vaccines · doi:10.4161/hv.6.1.9654 · Cited by 132
Wu, Y., Przysiecki, C. T., Flanagan, E., Bello‐Irizarry, S. N., Ionescu, R. M., Muratova, O. V., Dobrescu, G., Lambert, L., Keister, D. B., Rippeon, Y., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608545103 · Cited by 130
Self-citationLangreth, S. G., & Peterson, E. S. (1985) · Infection and Immunity · doi:10.1128/iai.47.3.760-766.1985 · Cited by 128
Chowdhury, D. R., Angov, E., Kariuki, T., & Kumar, N. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006352 · Cited by 124
Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro
Blagborough, A. M., & Sinden, R. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.069 · Cited by 123
Safety and immunogenicity of GMZ2 — a MSP3–GLURP fusion protein malaria vaccine candidate
Esen, M., Kremsner, P. G., Schleucher, R. D., Gässler, M., Imoukhuede, E. B., Imbault, N., Leroy, O. Y., Jepsen, S. V., Knudsen, B. W., Schumm, M., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.011 · Cited by 114
Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
Thompson, F. M., Porter, D. W., Okitsu, S. L., Westerfeld, N., Vogel, D., Todryk, S. M., Poulton, I. D., Correa, S., Hutchings, C. L., Berthoud, T. K., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001493 · Cited by 112
Guinovart, C., Aponte, J. J., Sacarlal, J., Aíde, P., Leach, A. J., Bassat, Q., Macete, E., Dobaño, C., Lievens, M., Loucq, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005165 · Cited by 108
Kester, K. E., McKinney, D., Tornieporth, N., Ockenhouse, C. F., Heppner, D. G., Hall, T., Wellde, B. T., White, K., Sun, P., Schwenk, R., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.005 · Cited by 107
Roestenberg, M., Remarque, E. J., de Jonge, E., Hermsen, R. C., Blythman, H., Leroy, O. Y., Imoukhuede, E. B., Jepsen, S. V., Ofori‐Anyinam, O., Faber, B. W., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003960 · Cited by 107
Celada, A., Cruchaud, A., & Perrin, L. H. (1982) · PubMed · Cited by 106
CLYDE, D. F. (1990) · PubMed · Cited by 105
Trimnell, A. R., Takagi, A., Gupta, M., Richie, T. L., Kappe, S. H. I., & Wang, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900302 · Cited by 95
Hermsen, C. C., Verhage, D. F., Telgt, D., Teelen, K., Bousema, T., Roestenberg, M., Bolad, A. K., Berzins, K., Corradin, G., Leroy, O. Y., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.081 · Cited by 92
Cummings, J. F., Spring, M., Schwenk, R., Ockenhouse, C. F., Kester, K. E., Polhemus, M. E., Walsh, D. S., Yoon, I., Prosperi, C., Juompan, L. Y., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.046 · Cited by 90
Sagara, I., Ellis, R. D., Dicko, A., Niambele, M. B., Kamaté, B., Guindo, O., Sissoko, M. S., Fay, M. P., Guindo, M. A., Kante, O., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.087 · Cited by 84
Self-citationEllis, R., Martin, L. B., Shaffer, D., Long, C., Miura, K., Fay, M. P., Narum, D., Zhu, D.-M., Mullen, G. E., Mahanty, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008787 · Cited by 84
Self-citationThe pre-erythrocytic stage of plasmodium falciparum
Shortt, H. E., Fairley, N. H., Covell, G., Shute, P. G., & Garnhám, P. C. C. (1951) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(51)80019-1 · Cited by 83
Baird, J. K., Purnomo, P., Basri, H., Bangs, M. J., ANDERSEN, E. M., Jones, T. R., Masbar, S., Harjosuwarno, S., Subianto, B., & Arbani, P. R. (1993) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.49.707 · Cited by 73
Minimal variation in a vaccine candidate from the sexual stage of Plasmodium falciparum
Kaslow, D. C., Quakyi, I. A., & Keister, D. B. (1989) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(89)90134-5 · Cited by 70
Sahly, H. M. E., Patel, S. M., Atmar, R. L., Lanford, T. A., Dube, T. J. T., Thompson, D. J. S., Sim, B. K. L., Long, C., & Keitel, W. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00082-10 · Cited by 69
Measurement of malaria vaccine efficacy in phase III trials: Report of a WHO consultation
Moorthy, V., Reed, Z. H., & Smith, P. G. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.085 · Cited by 66
Sexual-Stage Antibody Responses to P. falciparum in Endemic Populations
Bousema, T., DRAKELEY, C. J., & Sauerwein, R. W. (2006) · Current Molecular Medicine · doi:10.2174/156652406776055140 · Cited by 61
Genton, B., Pluschke, G., Degen, L. P., Kammer, A. R., Westerfeld, N., Okitsu, S. L., Schroller, S., Vounatsou, P., Mueller, M. M., Tanner, M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001018 · Cited by 59
Okitsu, S. L., Silvie, O., Westerfeld, N., Curcic, M., Kammer, A. R., Mueller, M. S., Sauerwein, R. W., Robinson, J. A., Genton, B., Mazier, D., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001278 · Cited by 52
Avril, M., Cartwright, M. M., Hathaway, M. J., Hommel, M., Elliott, S. R., Williamson, K., Narum, D. L., Duffy, P. E., Fried, M., Beeson, J. G., et al. (2010) · Infection and Immunity · doi:10.1128/iai.00410-09 · Cited by 44
Efficacy model for mosquito stage transmission blocking vaccines for malaria
Saul, A. J. (2008) · Parasitology · doi:10.1017/s0031182008000280 · Cited by 34
Genton, B., D’Acremont, V., Lurati, F., Verhage, D., Audran, R., Hermsen, C. C., Wolters, L., Reymond, C., Spertini, F., & Sauerwein, R. W. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.067 · Cited by 31
Olotu, A., Fegan, G., & Bejon, P. (2010) · The Journal of Infectious Diseases · doi:10.1086/651025 · Cited by 24
Malaria funding and resource utilization: the first decade of Roll Back Malaria.
Johansson, E. W., Cibulskis, R. E., & Steketee, R. W. (2010) · Cited by 23
Increasing incidence of malaria in the Negro River basin, Brazilian Amazon
Cabral, A. C., Fé, N. F., Suárez-Mútis, M. C., Bóia, M. N., & Carvalho-Costa, F. A. (2010) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2010.03.008 · Cited by 20
Research works printed but not linked: 23
- Pinzon-Charry, 2010, J Clin Invest., 120, 2967, 10.1172/JCI39222 · doi:10.1172/jci39222
- Carter, 1979, Bull World Health Organ., 57, 37
- Nussenzweig, 1986, Am J Trop Med Hyg., 35, 678, 10.4269/ajtmh.1986.35.678 · doi:10.4269/ajtmh.1986.35.678
- Walther, 2006, Infect Immun., 74, 2706, 10.1128/IAI.74.5.2706-2716.2006 · doi:10.1128/iai.74.5.2706-2716.2006
- 10.1016/j.vaccine.2004.08.020 · doi:10.1016/j.vaccine.2004.08.020
- Kubler-Kielb, 2010, Proc Natl Acad Sci U S A., 107, 1172, 10.1073/pnas.0913374107 · doi:10.1073/pnas.0913374107
- Clyde, 1990, Bull World Health Organ., 68, 9
- Celada, 1982, Clin Exp Immunol., 47, 635
- 10.1128/IAI.74.2.1412-1415.2006 · doi:10.1128/iai.74.2.1412-1415.2006
- 10.1128/AAC.49.10.4421-4422.2005 · doi:10.1128/aac.49.10.4421-4422.2005
- Sagara, 2009, Vaccine., 27, 3090, 10.1016/j.vaccine.2009.03.014 · doi:10.1016/j.vaccine.2009.03.014
- 10.1371/journal.pone.0007549 · doi:10.1371/journal.pone.0007549
- 10.1371/journal.pmed.0020344 · doi:10.1371/journal.pmed.0020344
- Horii, 2010, Parasitol Int., 59, 380, 10.1016/j.parint.2010.05.002 · doi:10.1016/j.parint.2010.05.002
- Malkin, 2008, Vaccine., 26, 6864, 10.1016/j.vaccine.2008.09.081 · DOI
- 10.1111/j.1365-3024.2009.01138.x · doi:10.1111/j.1365-3024.2009.01138.x
- Takala, 2009, Sci Transl Med., 1, 2ra5, 10.1126/scitranslmed.3000257 · DOI
- 10.1016/j.vaccine.2008.02.020 · doi:10.1016/j.vaccine.2008.02.020
- 10.1084/jem.160.3.935 · doi:10.1084/jem.160.3.935
- 10.1084/jem.180.1.297 · doi:10.1084/jem.180.1.297
- Guttinger, 1988, EMBO J., 7, 2555, 10.1002/j.1460-2075.1988.tb03104.x · doi:10.1002/j.1460-2075.1988.tb03104.x
- 10.1038/334258a0 · doi:10.1038/334258a0
- 10.1371/journal.pone.0005254 · doi:10.1371/journal.pone.0005254
Cited by
Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes
Bushell, E., Gomes, A. R., Sanderson, T., Anar, B., Girling, G., Herd, C., Metcalf, T., Modrzynska, K., Schwach, F., Martin, R. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.030 · Cited by 559
Malaria: The Past and the Present
Talapko, J., Škrlec, I., Alebić, T., Jukić, M., & Včev, A. (2019) · Microorganisms · doi:10.3390/microorganisms7060179 · Cited by 395
Crompton, P. D., Moebius, J., Portugal, S., Waisberg, M., Hart, G., Garver, L. S., Miller, L. H., Barillas-Mury, C., & Pierce, S. K. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120220 · Cited by 317
Self-citationTakem, E. N., & D'Alessandro, U. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.010 · Cited by 185
Metadata
- Authors
- Crompton, P. D., Pierce, S. K., & Miller, L. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2010-12-01
- Volume
- 120
- Issue
- 12
- Pages
- 4168-4178
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2131277865
- Cited by
- 269
- References
- 104
- FWCI
- 28.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.